Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMVA; USOTC: CPTRF) announced today its intention to commence a normal course issuer bid (“NCIB” or the “Bid”) to expend up to an aggregate of CDN $5 million on the purchase of common shares of the Company (the “Shares”). The actual number of Shares that may be purchased under the Bid, the value of the consideration per Share, and the exact timing of any such purchases will be determined by the Company and will depend on, among other things, future market conditions.

“Captor is commencing the Bid because the Company believes the repurchase of its Shares for cancellation would be in the best interests of its shareholders,” said Captor Capital CEO, John Zorbas. “The market price of its Shares, affected as it is by both the current cannabis market and the COVID-19 pandemic, does not reflect the underlying value of the Company’s business and future prospects.”

Pursuant to the NCIB, the Company may, if considered advisable, purchase the Shares through the facilities of the Canadian Securities Exchange (“CSE”) and/or alternative trading systems, from time to time over the next 12 months, and shall not, in any event, exceed 5% of the issued Shares.

The Company has appointed Foster and Associates Financial Services Inc. to coordinate and facilitate its NCIB purchases. Purchases are expected to commence through the CSE and/or alternative trading systems on or about May 5, 2020 and will conclude on the earlier of the date on which purchases under the bid have been completed or March 31, 2021. All Shares purchased by the Company will be cancelled.

About Captor Capital

Captor Capital Corp. is a Canadian cannabis company listed on the Canadian Securities Exchange, the OTC, and the Frankfurt and Stuttgart stock exchanges. Captor provides recreational cannabis, as well as other high demand cannabis-based goods for consumption. The Company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis assets including the CHAI Cannabis Co. dispensaries in Santa Cruz and Monterey, CA and the related e-commerce and deliver assets. The Company also owns Mellow Extracts, based in Costa Mesa, CA (launch date to be determined).


Gavin Davidson, Communications Captor Capital Corp. 416-504-3978

Forward-Looking Statements


This press release contains or refers to forward-looking information and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.


Click here to connect with Captor Capital Corp. (CSE:CPTR, FRANKFURT:NMV, STUTTGART:NMVA, OTC:CPTRF) for an Investor Presentation.


Heritage Cannabis Holdings Corp. (CSE: CANN)(OTCQX: HERTF) (“Heritage” or the “Company”), today announced that it has executed a binding letter of intent (“LOI”) with IntelGenx Corp. (TSXV:IGX)(OTCQB:IGXT) (“IntelGenx”), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, for the supply of filmstrip products containing CBD (“CBD Filmstrips”) for the Canadian and Australian markets.

Pursuant to the LOI and subject to entering into a Definitive Supply Agreement and the satisfaction of customary closing conditions, IntelGenx will manufacture filmstrips containing 10 mg of CBD using its VersaFilm® technology, for distribution and sale in Canada and Australia. In addition to receiving a manufacturing margin, IntelGenx will also receive a double-digit royalty on the gross margin based on product sales. Heritage will supply CBD material for IntelGenx’s filmstrip manufacture and supply in Canada and Australia on a non- and semi-exclusive basis, respectively. The LOI contemplates an option on future co-development of CBD and THC filmstrips using proprietary technology from both companies, under certain conditions.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) announces that it has received a Natural Health Product (“NHP”) number (#80105697) from Health Canada for its plant-based, antimicrobial, antiseptic skin ointment. This product was developed after promising results from the Company’s research of certain plant-based compounds for antimicrobial activity against pathogens for potential antiviral treatments. This will be Better Plants fourth Health Canada approval in 2020.

Cannot view this image? Visit:

Keep reading... Show less

Anticipates Q1-21 launch for the highly anticipated beverage and distillate vape lines

 Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (“BevCanna” or the “Company”) is pleased to announce that it has completed its first round of product launch discussions with select provincial buyers throughout Canada . During these in-depth product launch discussions, BevCanna validated its strategy of delivering established U.S. brands to Canadian consumers. Initial provincial feedback has enabled BevCanna to finalize its award-winning lineup of Keef Beverages and Cali -Bloom products, allowing the team to complete the Notice of New Cannabis Product Forms (“NNCP”).

Keep reading... Show less

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peabody Energy Corporation (NYSE: BTU), Tactile Systems Technology, Inc. (NASDAQ: TCMD), Pintec Technology Holdings Limited (NASDAQ: PT), and Aurora Cannabis, Inc. (NYSE: ACB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Peabody Energy Corporation (NYSE: BTU)

Keep reading... Show less

 GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company”) announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting provisions where 1,000,000 options will vest immediately and 400,000 options will vest 25% per quarter commencing October 31, 2020.

About GreenStar

Keep reading... Show less